Electromed (NYSE:ELMD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Electromed, Inc. to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference [Yahoo! Finance]
How Recent Developments Are Rewriting the Story for Electromed [Yahoo! Finance]
Electromed (NYSE:ELMD) had its "buy" rating reaffirmed by analysts at Roth Capital. They now have a $36.00 price target on the stock, up previously from $35.00.
Electromed outlines ongoing double-digit growth and hospital channel expansion with 15% revenue increase [Seeking Alpha]